Your session is about to expire
← Back to Search
Phenolic Compounds
Grapes for Sarcopenia
N/A
Recruiting
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Hand-grip strength media value of 16 kg or lower
Healthy postmenopausal women aged 60 years and older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights
Study Summary
This trial evaluates if the phenolic compounds in grape can help reduce muscle loss in elderly people or those with chronic diseases.
Who is the study for?
This trial is for healthy postmenopausal women over 60 with a normal BMI (18.4-24.9), hand-grip strength ≤16 kg, blood pressure <130/80 mmHg, and glucose & cholesterol levels below 100 and 200 mg/dl respectively. Excluded are those with muscle diseases, vascular disease, diabetes, recent heart attack or severe infection treatment, weight under 140 lbs., anemia or recent blood donation.Check my eligibility
What is being tested?
The study tests if daily grape powder supplements can help prevent muscle loss in elderly women by comparing it to a placebo. It's based on the idea that grapes might boost protective myokines like irisin which could fight sarcopenia—a condition of losing muscle mass and function.See study design
What are the potential side effects?
While not explicitly stated in the provided information, potential side effects from grape powder supplementation may include digestive discomfort or allergic reactions; however these are generally considered low-risk interventions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My hand-grip strength is 16 kg or less.
Select...
I am a healthy woman aged 60 or older and have gone through menopause.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Plasma irisin levels
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: grape groupExperimental Treatment1 Intervention
The participant of this group will received a lyophilized grape powder
Group II: placebo groupPlacebo Group1 Intervention
The participant of this group will received a lyophilized powder similar to the grape one
Find a Location
Who is running the clinical trial?
University of California, DavisLead Sponsor
910 Previous Clinical Trials
4,706,977 Total Patients Enrolled
California Table Grape CommissionOTHER
6 Previous Clinical Trials
213 Total Patients Enrolled
Francene G Steinberg, PhDStudy ChairUniversity of California, Davis
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have experienced significant weight loss and muscle wasting.I weigh less than 140 pounds.I have had a heart attack.I have anemia and haven't donated blood in the last 30 days.I have been diagnosed with diabetes.You have a healthy weight, with a BMI between 18.4 and 24.9.My hand-grip strength is 16 kg or less.I am a healthy woman aged 60 or older and have gone through menopause.I have a liver condition.I am on dialysis.I am on long-term steroid therapy.I have been diagnosed with peripheral vascular disease.You have a history of certain muscle diseases.Your blood pressure, blood sugar, and cholesterol levels are too low.I am currently undergoing treatment for cancer or a severe infection.I experience leg pain when I walk.I have a disorder affecting my brain or nerves.I have had a stroke.
Research Study Groups:
This trial has the following groups:- Group 1: grape group
- Group 2: placebo group
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many participants are actively being monitored in this clinical investigation?
"Affirmative. According to the details hosted on clinicaltrials.gov, this medical trial was opened for recruitment in April of 2023 and is still active today, having been updated as recently as May 15th 2023. The study aims to enrol 14 patients at one specific site."
Answered by AI
Are additional participants being accepted to this research project?
"Indeed, according to clinicaltrials.gov, the study opened for enrolment on April 1st of this year and was recently updated on May 15th. 14 individuals are required from one medical centre for participation in the trial."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger